Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 25

1.

Muir-Torre Syndrome With a Frame-shift Mutation in the MSH2 Gene: A Rare Case Report and Literature Review.

Chen Q, Wang M, Xu Z, Wang M, Jin S, Tian S, Xiao S.

Int J Gynecol Pathol. 2020 Mar;39(2):136-140. doi: 10.1097/PGP.0000000000000572.

PMID:
32039937
2.

Evaluation of changes in magnetic resonance diffusion tensor imaging after treatment of delayed encephalopathy due to carbon monoxide poisoning.

Wu J, Peng T, Xu Z, Yang X, Zhao L, Yang H, Zhao D.

J Integr Neurosci. 2019 Dec 30;18(4):475-479. doi: 10.31083/j.jin.2019.04.160.

3.

Isolation and characterization of spontaneously immortalized B-lymphocyte lines from HIV-infected patients with and without non-Hodgkin's Lymphoma.

Zhuang K, Zhang Y, Zhou L, Qi X, Xu X, Meng F, Xu Z, Liu J, Shao L, Liu H, Liu H, Fang J, Deng D, Peng J, Zhou F, Liu L, Tang H, Xiong Y, Ho W, Guo D, Ke H, Gui X.

Cancer Med. 2019 Nov;8(15):6741-6755. doi: 10.1002/cam4.2508. Epub 2019 Sep 20.

4.

The effect of an alternative chromosome 17 probe on fluorescence in situ hybridization for the assessment of HER2 amplification in invasive breast cancer.

Xu Z, Xu P, Fan W, Huang B, Cheng Q, Zhang Z, Wang P, Yu M.

Exp Ther Med. 2019 Sep;18(3):2095-2103. doi: 10.3892/etm.2019.7756. Epub 2019 Jul 9.

5.

USP49 negatively regulates cellular antiviral responses via deconjugating K63-linked ubiquitination of MITA.

Ye L, Zhang Q, Liuyu T, Xu Z, Zhang MX, Luo MH, Zeng WB, Zhu Q, Lin D, Zhong B.

PLoS Pathog. 2019 Apr 3;15(4):e1007680. doi: 10.1371/journal.ppat.1007680. eCollection 2019 Apr.

6.

USP20 Promotes Cellular Antiviral Responses via Deconjugating K48-Linked Ubiquitination of MITA.

Zhang MX, Cai Z, Zhang M, Wang XM, Wang Y, Zhao F, Zhou J, Luo MH, Zhu Q, Xu Z, Zeng WB, Zhong B, Lin D.

J Immunol. 2019 Apr 15;202(8):2397-2406. doi: 10.4049/jimmunol.1801447. Epub 2019 Feb 27.

PMID:
30814308
7.

Muir-Torre Syndrome With a Frame-shift Mutation in the MSH2 Gene: A Rare Case Report and Literature Review.

Chen Q, Wang M, Xu Z, Wang M, Jin S, Tian S, Xiao S.

Int J Gynecol Pathol. 2018 Dec 3. doi: 10.1097/PGP.0000000000000572. [Epub ahead of print]

PMID:
30516620
8.

Expression of the Chemokine Receptor CXCR3 Correlates with Dendritic Cell Recruitment and Prognosis in Gastric Cancer.

Chen F, Yin S, Niu L, Luo J, Wang B, Xu Z, Yang G.

Genet Test Mol Biomarkers. 2018 Jan;22(1):35-42. doi: 10.1089/gtmb.2017.0125. Epub 2017 Dec 21.

PMID:
29266971
9.

The diagnostic value of microRNA-4787-5p and microRNA-4306 in patients with acute aortic dissection.

Wang L, Zhang S, Xu Z, Zhang J, Li L, Zhao G.

Am J Transl Res. 2017 Nov 15;9(11):5138-5149. eCollection 2017.

10.

Risk of infection in patients with spondyloarthritis and ankylosing spondylitis receiving antitumor necrosis factor therapy: A meta-analysis of randomized controlled trials.

Xu Z, Xu P, Fan W, Yang G, Wang J, Cheng Q, Yu M.

Exp Ther Med. 2017 Oct;14(4):3491-3500. doi: 10.3892/etm.2017.5003. Epub 2017 Aug 22.

11.

Intraductal tubulopapillary neoplasm accompanied by invasive carcinoma of the pancreas: A case report and review of the literature.

Niu L, Xu Z, Liu H, Cao H, Yang G.

Mol Clin Oncol. 2017 May;6(5):676-682. doi: 10.3892/mco.2017.1216. Epub 2017 Apr 10.

12.

Risk of tuberculosis in patients treated with TNF-α antagonists: a systematic review and meta-analysis of randomised controlled trials.

Zhang Z, Fan W, Yang G, Xu Z, Wang J, Cheng Q, Yu M.

BMJ Open. 2017 Mar 22;7(3):e012567. doi: 10.1136/bmjopen-2016-012567. Review.

13.

Inhibiting tumor necrosis factor-alpha diminishes desmoplasia and inflammation to overcome chemoresistance in pancreatic ductal adenocarcinoma.

Zhao X, Fan W, Xu Z, Chen H, He Y, Yang G, Yang G, Hu H, Tang S, Wang P, Zhang Z, Xu P, Yu M.

Oncotarget. 2016 Dec 6;7(49):81110-81122. doi: 10.18632/oncotarget.13212.

14.

Circulating Resistin Levels and Risk of Colorectal Cancer: A Meta-Analysis.

Yang G, Fan W, Luo B, Xu Z, Wang P, Tang S, Xu P, Yu M.

Biomed Res Int. 2016;2016:7367485. doi: 10.1155/2016/7367485. Epub 2016 Aug 24. Review.

15.

Corrigendum to "Overexpression of the chemokine receptor CXCR3 and its correlation with favorable prognosis in gastric cancer" (Hum Pathol 2015;46:1872-1880).

Hu M, Li K, Maskey N, Xu Z, Yu F, Peng C, Li Y, Yang G.

Hum Pathol. 2016 Aug;54:203-204. doi: 10.1016/j.humpath.2016.05.001. Epub 2016 Jun 16. No abstract available.

PMID:
27318388
16.

Ligustilide treatment promotes functional recovery in a rat model of spinal cord injury via preventing ROS production.

Xiao W, Yu A, Liu D, Shen J, Xu Z.

Int J Clin Exp Pathol. 2015 Oct 1;8(10):12005-13. eCollection 2015.

17.

Overexpression of the chemokine receptor CXCR3 and its correlation with favorable prognosis in gastric cancer.

Hu M, Li K, Maskey N, Xu Z, Yu F, Peng C, Li Y, Yang G.

Hum Pathol. 2015 Dec;46(12):1872-80. doi: 10.1016/j.humpath.2015.08.004. Epub 2015 Aug 24.

PMID:
26434630
18.

15-PGDH expression as a predictive factor response to neoadjuvant chemotherapy in advanced gastric cancer.

Hu M, Li K, Maskey N, Xu Z, Peng C, Tian S, Li Y, Yang G.

Int J Clin Exp Pathol. 2015 Jun 1;8(6):6910-8. eCollection 2015.

19.

Impact of neoadjuvant chemotherapy on lymphocytes and co-inhibitory B7-H4 molecule in gastric cancer: low B7-H4 expression associates with favorable prognosis.

Maskey N, Li K, Hu M, Xu Z, Peng C, Yu F, Cao H, Chen J, Li Y, Yang G.

Tumour Biol. 2014 Dec;35(12):11837-43. doi: 10.1007/s13277-014-2410-2. Epub 2014 Sep 27.

PMID:
25260881
20.

Decreased intratumoral Foxp3 Tregs and increased dendritic cell density by neoadjuvant chemotherapy associated with favorable prognosis in advanced gastric cancer.

Hu M, Li K, Maskey N, Xu Z, Peng C, Wang B, Li Y, Yang G.

Int J Clin Exp Pathol. 2014 Jul 15;7(8):4685-94. eCollection 2014.

Supplemental Content

Loading ...
Support Center